liraglutide
Read all at 
http://www.medicaldaily.com/articles/15910/20130526/diabetes-drug-sold-weight-loss-medication.htm
Danish pharmaceutical company Novo Nordisk announced plans to re-brand and sell its diabetes drug liraglutide (Victoza) as a weight loss drug for obese people by 2015. Currently, the drug is approved and sold to help regulate insulin production in people living with type 2 diabetes.
